Comment on: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”
Crossref DOI link: https://doi.org/10.1007/s40265-018-0918-2
Published Online: 2018-05-21
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pires, Antonio
Goyal, Kavitha
Greenspan, Andrew
Text and Data Mining valid from 2018-05-21
Article History
First Online: 21 May 2018
Compliance with ethical standards
:
: All authors are employees of Janssen Pharmaceuticals and own or owned stock in Johnson & Johnson.